• The Deadly Business of an Unregulated Global Stem Cell Industry 

      Lysaght, T; Lipworth, W; Hendl, T; Kerridge, I; Munsie, M; Waldby, C; Stewart, C
      Published 2017-03-29
      In 2016, the Office of the State Coroner of New South Wales released its report into the death of an Australian woman, Sheila Drysdale, who had died from complications of an autologous stem cell procedure at a Sydney clinic. ...
      Open Access
      Article
    • The direct-to-consumer market for stem cell-based interventions in Australia: Exploring the experiences of patients Special Report 

      Waldby, C; Hendl, T; Kerridge, I; Lipworth, W; Lysaght, T; Munsie, M; Stewart, C
      Published 2020-01-01
      The prevalence of businesses selling autologous stem cell-based interventions (ASCBI) to patients in Australia has raised serious concerns about how weaknesses in regulation have enabled the emergence of an industry that ...
      Open Access
      Article
    • Regulating the Stem Cell Industry: Needs and Responsibilities 

      Lee, TL; Lysaght, T; Lipworth, W; Hendl, T; Kerridge, I; Munsie, M; Stewart, C
      Published 2017-07-01
      Emerging biotechnologies pose public health challenges1 because of both the known and unforeseen risks they carry, the uncertain medical benefits they offer, the speed at which they have disseminated and their unproven ...
      Open Access
      Article
    • The Stem Cell “Sell” 

      Munsie, M; Kerridge, I; Stewart, C; Hendl, T; Lipworth, W; Lysaght, T; Waldby, C
      Published 2016-08-01
      In recent years, a growing number of clinics in Australia and overseas have begun to offer therapies that claim to restore health by using stem cells to replace or repair the patient's faulty or missing cells. For those ...
      Open Access
      Article